Bottom line
What does CANC hold?
CANC held 57 positions as of May 31, 2026. Its largest holding is Revolution Medicines Inc at 7.73% of the fund, and the top 10 positions add up to 42.9%. By asset type it is 99% stocks, 1% cash & short-term funds.
Updated Jul 29, 2026
CANC top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Revolution Medicines Inc RVMD | Stocks | 7.73% | $13.6M |
| 2 | Eli Lilly & Co LLY | Stocks | 4.82% | $8.5M |
| 3 | Roche Holding AG RHHBY | Stocks | 4.21% | $7.4M |
| 4 | Cogent Biosciences Inc COGT | Stocks | 4.10% | $7.2M |
| 5 | Novartis AG NOVN | Stocks | 4.03% | $7.1M |
| 6 | Immunome Inc IMNM | Stocks | 3.91% | $6.9M |
| 7 | Celcuity Inc CELC | Stocks | 3.58% | $6.3M |
| 8 | Merck & Co Inc MRK | Stocks | 3.57% | $6.3M |
| 9 | AstraZeneca PLC AZN | Stocks | 3.54% | $6.2M |
| 10 | Nuvalent Inc NUVL | Stocks | 3.37% | $5.9M |
| 11 | Bristol-Myers Squibb Co BMY | Stocks | 3.30% | $5.8M |
| 12 | Legend Biotech Corp LEGN | Stocks | 2.99% | $5.3M |
| 13 | AbbVie Inc ABBV | Stocks | 2.81% | $4.9M |
| 14 | Exelixis Inc EXEL | Stocks | 2.78% | $4.9M |
| 15 | Bridgebio Pharma Inc BBIO | Stocks | 2.75% | $4.8M |
| 16 | Johnson & Johnson JNJ | Stocks | 2.55% | $4.5M |
| 17 | CG oncology Inc CGON | Stocks | 2.43% | $4.3M |
| 18 | Genmab A/S GMAB | Stocks | 2.37% | $4.2M |
| 19 | Ideaya Biosciences Inc IDYA | Stocks | 2.27% | $4.0M |
| 20 | Amgen Inc AMGN | Stocks | 2.11% | $3.7M |
| 21 | Zai Lab Ltd ZLAB | Stocks | 1.98% | $3.5M |
| 22 | BeOne Medicines Ltd ONC | Stocks | 1.88% | $3.3M |
| 23 | Zymeworks Inc ZYME | Stocks | 1.51% | $2.7M |
| 24 | Enliven Therapeutics Inc ELVN | Stocks | 1.31% | $2.3M |
| 25 | Relay Therapeutics Inc RLAY | Stocks | 1.28% | $2.3M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 29, 2026